Does VINBLASTINE Cause Second primary malignancy? 170 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 170 reports of Second primary malignancy have been filed in association with VINBLASTINE (Vinblastine Sulfate). This represents 3.2% of all adverse event reports for VINBLASTINE.
170
Reports of Second primary malignancy with VINBLASTINE
3.2%
of all VINBLASTINE reports
86
Deaths
34
Hospitalizations
How Dangerous Is Second primary malignancy From VINBLASTINE?
Of the 170 reports, 86 (50.6%) resulted in death, 34 (20.0%) required hospitalization, and 16 (9.4%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINBLASTINE. However, 170 reports have been filed with the FAERS database.
What Other Side Effects Does VINBLASTINE Cause?
Off label use (508)
Febrile neutropenia (498)
Neutropenia (416)
Drug ineffective (302)
Product use in unapproved indication (265)
Disease progression (262)
Pyrexia (259)
Neuropathy peripheral (258)
Nausea (215)
Vomiting (172)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which VINBLASTINE Alternatives Have Lower Second primary malignancy Risk?
VINBLASTINE vs VINCRISTINE
VINBLASTINE vs VINDESINE
VINBLASTINE vs VINORELBINE
VINBLASTINE vs VINORELBINE\VINORELBINE
VINBLASTINE vs VIREAD